Phan T, Ribeiro RM, Edelstein GE, Boucau J, et al. Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance. J Virol 2025 Feb 4:e0162324. doi: 10.1128/jvi.01623.
PMID: 39902924